Similarities and Difference Between HMPV and Covid-19 Virus

Human Metapneumovirus (HMPV), first identified in 2001, is a respiratory virus from the Pneumoviridae family. Similar to respiratory syncytial virus (RSV), it causes upper and lower respiratory infections and primarily affects young children, the elderly, and immunocompromised individuals. Recently, India reported two cases in Bengaluru, raising concerns about its spread and impact. Here’s an in-depth look at HMPV.

Key Aspects of HMPV

What is HMPV?

• Discovered in 2001; part of the Pneumoviridae family.
• Causes respiratory infections resembling colds or flu.
• Threatens children, the elderly, and people with weakened immune systems.
• Circulates globally; prevalent in winter and spring.

Symptoms

• Mild symptoms
• Cough, fever, runny/stuffy nose, sore throat.
• Shortness of breath, wheezing.
• Severe cases
• Bronchitis, pneumonia, asthma, and ear infections.
• High-risk groups: young children, adults over 65, immunocompromised individuals.

Spread and Infection Period

• Transmitted via respiratory droplets from coughing or sneezing.
• Spread through close contact or contaminated surfaces.
• Infection lasts 3-5 days; immunity from prior infections is insufficient to prevent reinfection.

Diagnosis and Treatment

• Diagnosed via nasal or throat swab testing.
• Severe cases may require chest X-rays or bronchoscopy.
• No specific antiviral treatment or vaccine available.
• Treatments for severe cases,
• Oxygen therapy.
• Intravenous fluids for hydration.
• Corticosteroids for inflammation.

Preventive Measures

• Frequent handwashing with soap and water.
• Avoid touching the face with unwashed hands.
• Wear masks in crowded areas.
• Stay home when unwell.
• Regularly clean frequently touched surfaces.

HMPV vs Covid-19 Virus

Similarities

• Both cause respiratory symptoms like fever, cough, congestion, and shortness of breath.
• Spread through respiratory droplets.

Differences

• HMPV: No vaccine or antiviral treatment; primarily seasonal (winter-spring).
• COVID-19: Vaccines and antiviral treatments available; associated with more severe global impact.

Global Response and Concerns

• Outbreak in China
• Overcrowded hospitals reported; HMPV cases on the rise.
• Chinese government assures it’s a regular seasonal occurrence.
• Neighboring Countries
• Hong Kong, Taiwan, Malaysia, and Japan monitoring cases closely.
• Malaysia reported a 45% rise in cases from 2023 to 2024.
• Japan noted a simultaneous influenza outbreak with over 94,000 cases.